Skip to main content
HERAMED LIMITED logo

HERAMED LIMITED — Investor Relations & Filings

Ticker · HMD ISIN · AU0000028367 LEI · 875500WOB41XBFTTJ477 ASX Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2019-08-11 Capital/Financing Update
Country AU Australia
Listing ASX HMD

About HERAMED LIMITED

https://hera-med.com/

HeraMED Limited is a medical technology company specializing in the development and commercialization of digital health solutions for maternity care. The company focuses on providing remote monitoring tools that bridge the gap between expectant mothers and healthcare providers. Its flagship product, HeraBEAT, is a medical-grade, smartphone-based fetal heart rate monitor designed for home use, allowing for accurate and reliable monitoring of fetal well-being. This hardware is integrated into the HeraCARE platform, a comprehensive digital maternity care solution that enables remote data management, personalized care plans, and seamless communication between patients and clinicians. By leveraging cloud-based technology and advanced sensors, the company aims to enhance prenatal care, improve clinical outcomes, and offer peace of mind through continuous, data-driven insights throughout the pregnancy journey.

Recent filings

Filing Released Lang Actions
HeraMED enters the German market with initial PO secured 2 pages 198.6KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated 12 August 2019, detailing a business development where HeraMED has secured an initial purchase order with a European distributor for its medical device. The content focuses on a commercial deal and market entry strategy rather than financial results, regulatory filings, or management changes. There are no financial statements, earnings data, or regulatory compliance information. The document is a corporate announcement about a commercial partnership and market expansion, which fits best under the category of Capital/Financing Update (CAP) as it relates to business development and potential revenue growth through new distribution channels. The document length is 5715 characters, which is sufficient for a detailed announcement but does not contain financial report data or meeting materials. Therefore, the most appropriate classification is CAP with high confidence.
2019-08-11 English
June Quarterly Activities Report & Appendix 4C 8 pages 366.9KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Activities Report' and provides detailed operational updates and financial data for the three-month period ended 30 June 2019. It includes a comprehensive Appendix 4C quarterly report, which is a regulatory requirement for entities listed on the ASX under Listing Rule 4.7B. The report contains actual financial statements such as cash flow statements, cash balances, and payments to directors, indicating substantive financial data. The length of the document (15,000 characters) and the detailed financial and operational content confirm it is a full quarterly report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q2 2019
2019-07-30 English
HeraCARE Investor Presentation July 2019 15 pages 2.1MB
Regulatory Filings
2019-07-21 English
HeraCARE PRO Integrated into Hapvidas Hospital Systems 3 pages 342.7KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 1 July 2019 from HeraMED Limited providing an update on the integration of its HeraCARE PRO platform into Hapvida's hospital systems. It discusses the progress of a pilot trial, technical integration, product validation, and future plans. The content is focused on business development and operational updates rather than financial results, regulatory filings, or management changes. There is no indication of financial statements, audit information, voting results, or executive changes. The document is a corporate announcement about product and partnership progress, which fits best under the category of a general regulatory announcement or compliance update. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2019-06-30 English
HeraBEAT Australian B2C launch underway 3 pages 344.1KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated 19 June 2019 providing an update on the Australian B2C launch of HeraMED's medical device HeraBEAT. It discusses the launch of a dedicated website, marketing campaign details, and strategic partnerships. There are no financial statements, earnings data, or regulatory filings such as annual or interim reports. The content focuses on a business update related to product launch and marketing activities, which fits the category of a Capital/Financing Update or general business update. However, since it is specifically about a product launch and marketing campaign rather than fundraising or capital structure changes, the best fitting category is Capital/Financing Update (CAP) as it relates to commercial activities impacting company growth and capital deployment. The document length is about 5,196 characters, which is consistent with an announcement rather than a full report. Therefore, the classification is CAP with high confidence.
2019-06-18 English
Appendix 3B 14 pages 503.4KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including classes of securities, number of securities, issue prices, purposes, and compliance with ASX rules. It references ASX Listing Rules, shareholder approvals, and placement capacity calculations under rules 7.1 and 7.1A. The content is consistent with a formal announcement of new share issues and capital changes rather than a full financial report or earnings release. The document is lengthy (15,000 characters) and contains substantive details about the capital issuance process. Therefore, it fits the category of a capital or financing update rather than a regulatory filing or report publication announcement.
2019-06-13 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.